Neoechinulin A as a Promising SARS-CoV-2 M(pro) Inhibitor: In Vitro and In Silico Study Showing the Ability of Simulations in Discerning Active from Inactive Enzyme Inhibitors

The COVID-19 pandemic and its continuing emerging variants emphasize the need to discover appropriate treatment, where vaccines alone have failed to show complete protection against the new variants of the virus. Therefore, treatment of the infected cases is critical. This paper discusses the bio-gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhadrami, Hani A., Burgio, Gaia, Thissera, Bathini, Orfali, Raha, Jiffri, Suzan E., Yaseen, Mohammed, Sayed, Ahmed M., Rateb, Mostafa E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955780/
https://www.ncbi.nlm.nih.gov/pubmed/35323462
http://dx.doi.org/10.3390/md20030163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955780/
https://www.ncbi.nlm.nih.gov/pubmed/35323462
http://dx.doi.org/10.3390/md20030163

Ejemplares similares